Phase 2 Remyelination Trial Yields ' Intriguing ' Interim Results Phase 2 Remyelination Trial Yields ' Intriguing ' Interim Results

Interim blinded findings of the VISIONARY-MS trial suggest some overall improvement in visual impairment in MS patients with a potentially remyelinating agent or placebo.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news